Balaji, Seshadri http://orcid.org/0000-0001-5864-5125
Evers, Patrick D. http://orcid.org/0000-0002-9299-1926
Batra, Anjan S.
Moore, Jeremy http://orcid.org/0000-0003-3089-9005
Article History
Received: 25 February 2023
Accepted: 5 September 2023
First Online: 23 September 2023
Declarations
:
: Seshadri Balaji has received consulting fees from Milestone Pharmaceuticals and Janssen Pharmaceuticals.